Valdespino-Gómez VM, Valdespino-Castillo PM, Valdespino-Castillo VE

Language: Spanish
References: 43
Page: 578-589
PDF size: 421.91 Kb.

ABSTRACT

Regenerative medicine is a medical multidisciplinary area with the aim of morphologic and functional restoration of tissues or organs in order to re-establish normal function. The main bases of regenerative medicine are the use of autologous stem or progenitor cells and the ex vivo construction of physical-mechanical tissue structuring organization, which with stem cells may form bioartificial organs. Another eventual strategy is in vivo stem or progenitor cell stimulation for proliferation. Tissue engineering entirely combines the use of cells, biochemical and physicochemical factors, nanomaterials and bioengineering methods to improve or replace biological functions of tissues and organs.
The progressive understanding of the proliferation and differentiation of the process of stem cells and their in vitro manipulation has been the launching platform for the field of regenerative medicine.
In this review we describe the main strategies used for regenerative medicine in tissue regeneration along with the main obtained clinicalsurgical benefits.

REFERENCES

1. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol 2011;33(3):307-315.

2. Sánchez A, Schimmang T, Garcia-Sancho J. Cell and tissue therapy in regenerative medicine. Adv Exp Med Biol 2012;741:89-102.

3. Khatiwala C, Law R. Shepherd B, Dorfman S, Csete M. 3D Cell bio printing for regenerative medicine research and therapies. Gene Ther Reg 2012;7(1):1-19.

4. Kaiser LR. The future of multihospital systems. Top Health Care Financ 1992;18:32-45.

5. Riazi AM, Kwon SY, Standford WL. Stem Cell Sources for Regenerative Medicine. Methods Mol Biol 2009;482:55-90.

6. Sánchez A, Schimmang T, Garcia-Sancho J. Cell and tissue therapy in regenerative medicine. AdvExp Med Biol 2012;741:89-102.

7. Lodi D, Iannitti T, Palmieri B. Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res 2011;30:9.

8. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblast by Defined Factors. Cell 2007;131(5):861-872.

9. Green EM, Lee RT. Proteins and Small Molecules for Cellular Regenerative Medicine. Physiol Rev 2013;93(1):311-325.

10. Badylak SF, Taylor D, Uygun K. Whole-Organ Tissue Engineering: Decellularization and Recellularization of Three-Dimensional Matrix Scaffolds. Annu Rev Biomed Eng 2011;13:27-53.

11. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012;379(9819):943-952.

12. Papanas N, Eleftheriadou I, Tentolouris N, Maltezos E. Advances in the Topical Treatment of Diabetic Foot Ulcers. Curr Diabetes Rev 2012;8(3):209-218.

13. Li XJ, Valadez AV, Zuo P, Nie Z. Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis 2012;4(12):1509-1525.

14. Peran M, Garcia MA, Lopez-Ruiz E, Bustamante M, Jimenez G, Madeddu R, et al. Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci 2012;13:3847-3886.

15. Seliktar D. Designing cell-compatible hydrogels for biomedical applications. Science 2012;336:1124-1128.

16. Aora P, Sindhu A, Dilbaghi N, Chaudhury A, Rajakumar G, Rahuman AA. Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. J Cell Mol Med 2012;16:1991-2000.

17. Yukawa H, Kagami Y, Watanabe M, Oishi K, Miyamoto Y, Okamoto Y, et al. Quantum dots labeling using octaarginine peptides for imaging of adipose tissue-derived stem cells. Biomaterials 2010;31:4094-4103.

18. Wang J, Valmikinathan CM, Liu W, Larecin CT, Yu X. Spiralstructure, nanofibrous, 3D scaffolds of bone tissue engineering. J Biomed Mater Res A 2008;29:3815-3821.

19. Atala A, Kasper FK, Mikos AG. Engineering complex tissues. Science Transl Med 2012;4:160rv12.

20. Polak DJ. Regenerative medicine. Opportunities and challenges: a brief overview. J R Soc Interface 2010;7:S777-S781.

21. Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, et al. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (ProchymalTM) in pediatric patients with severe refractory acute graft-versushost disease in a compassionate use study. Biol Blood Marrow Transplant 2011;17:534-541.

22. Oldershaw RA. Cell sources for the regeneration of articular cartilage: the past, the horizon and the future. Int J Exp Pathol 2012;93:389-400.

23. Marchini G, Pedrotti E, Pedrotti M, Barbaro V, Di Iorio E, Ferrari S, et al. Long-term effectiveness of autologous cultured limbal stem cell grafts in patients with limbal stem cell deficiency due to chemical burns. Clin Experiment Ophtalmol 2012;40:255-267.

24. Pendyala L, Jabara R, Shinke T, Chronos N, Robinson K, Li J, et al. Drug-eluting stents:presentan future. Cardiovas Hematol Agents Med Chem 2008;6:105-115.

25. Fosnot J, Kovach SJ III, Serletti JM. Acellular Dermal Matrix. General Principles for the Plastic Surgeon. Aesthet Surg 2011;31(Suppl 7):5S-12S.

26. Van der Veen VC, van der Wal MB, van Leeuwen MC, Ulrich MM, Middelkoop E. Biological background of dermal sustitutes. Burns 2010;36:305-321.

27. Gigante A, Callegari L. The role of intra-articular hyaluronan (synovial) in the treatment of osteoarthritis. Rheumatol Int 2011;31:427-444.

28. Mar J, Romero Jurado M, Arrospide A, Enrique Fidalgo A, Soler Lopez B. Cost-analysis of viscosupplementation treatment with hyaluronic acid in candidate knee replacement patients with osteoarthritis. Rev Esp Ortop Traumotol 2013;57:6-14.

29. Clegg TE, Caborn D, Mauffrey C. Viscosupplementation with hyaluronic acid in the treatment for cartilage lesions: a review of current evidence and future directions. Eur J Orthop Surg Traumatol 2013;23:119-124.

30. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008;372:2023-2030.

31. Bader A, Macchiarini P. Moving towards in situ traqueal regeneration: the bionic tissue engineered transplantation approach. J Cell Mol Med 2010;14:1877-1889.

32. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologoous bladders for patients needing cystoplasty. Lancet 2006;367:1241-1246.

33. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozoky B, et al. Tracheobronchial transplantation with stem cell seeded bioartifical nanocomposite: a proof of concept study. Lancet 2011;328:1997-2004.

34. Elliot MJ, De Coppi P, Spegglorin S, Roebuck D, Butler CR, Samuel E, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet 2012;380:994-1000.

35. Ott HC. Engineering tissues for children: building grafts that grow. Lancet 2012;380:957-958.

36. Ruan J, Shen J, Wang Z, Ji J, Song H, Wong K, et al. Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology. Int J Nanomedicine 2011;6:425-435.

37. Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013;481-484. doi:10.1038/nature 12271.

38. Xu T, Zhao W, Zhu JM, Albanna MZ, Yoo JJ, Atala A. Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials 2013;34:130-139.

39. Koch L, Gruene M, Unger C, Chichkov B. Laser assisted cell printing. Curr Pharm Biotechnol 2013;14:91-97.

40. Marga F, Jakab K, Khatiwala C, Shepherd B, Dorfman S, Hubbard B, et al. Toward engineering functional organ modules by additive manufacturing. Biofabrication 2012;4(2):1-12.

41. Maher B. How to build a heart. Nature 2013;499:20-22.

42. Ptazek LM, Mansour M, Ruskin N, Chien KR. Towards regenerative therapy for cardiac disease. Lancet 2012;379:933-942.

43. Pashuck ET, Stevens MM. Designing Regenerative Biomaterial Therapies for Clinic. Science Transl Med 2012;4(160):160sr4.